Please review the November 8th 2022 COPE accredited webinar below as Dr. Joshua Teichman presented to 400+ ODs nationally on the New Clinical Evidence for Thealoz Duo and Thealoz Duo Gel which is supported by the ASCRS Guidelines (co-authored by Dr. Clara Chan) to Treat Ocular Surface Disease for Cataract and Refractive Surgery with aggressive use of Preservative-Free Artificial Tears to optimize surgical outcomes and improve patient satisfaction.
Labtician Théa is committed to eye care education. Contact us for upcoming COPE accredited webinars.
- Learn about the science associated with Trehalose and its impact on Ocular Surface
- Evaluate how Trehalose stabilizes tear film thickness, reduces inflammatory markers, restores osmotic balance and reduces dry eye symptoms
- Review new evidence in pre and post-operative surgical use of Trehalose to optimize patient outcomes
- Learn about complex dry eye patient cases from OD peers
Joshua C. Teichman, MD, FRCSC, MPH
Dr. Teichman studied Medicine at Western University, Ophthalmology at McMaster University, and a Cornea Surgical Fellowship at the University of Ottawa. Dr. Teichman has won numerous awards from the AAO, the ASCRS, and COS. Dr. Teichman is faculty at the University of Toronto. He is in private practice at Prism Eye Institute and TLC.
Relieve dry eyes with the bioprotection and osmoregulation of Thealoz® Duo. Preservative- and phosphate-free, Thealoz® Duo is a unique dry eye treatment that restores the eye’s normal environment by combining the bioprotective properties of trehalose and the moisturizing effect of sodium hyaluronate.